Therapy News and Research

RSS

Baylor College of Medicine and UH team up for new research collaborations

Baylor College of Medicine and the University of Houston are teaming up for new research collaborations.

10 Mar 2020

Research introduces a new concept of resectability in pancreatic cancer

Pancreatic cancer is predicted to become the second leading cause of cancer-related deaths by 2030. However, recent developments in staging and treatment provide options to improve the long-term survival rate for an otherwise devastating diagnosis.

10 Mar 2020

The second person cured from HIV goes public

In the 1980s and early 1990s, the outbreak of HIV and AIDS swept across the globe. Today, more than 70 million people have been infected with HIV, and about 35 million have died from AIDS since the start of the pandemic. However, scientific advances, such as the development of antiretroviral drugs, have enabled people with access to treatment to live long and healthy lives with HIV. But, there is still no vaccine and cure for it. In history, only two persons have been cleared of the infection, one in Berlin and now the second one in London.

10 Mar 2020

NCCN publishes recommendations for assessing quality improvements in cancer care

The National Comprehensive Cancer Network has published a curated list of high-impact measures for assessing quality improvements in cancer care.

10 Mar 2020

Music appears to decrease delirium in critically ill patients

It is common for critically ill patients on life support to develop delirium, a form of acute brain failure for which no effective treatment is known.

10 Mar 2020

Researchers find way to inactivate cancer protein with the help of another protein

Squamous cell carcinoma is a very unusual type of cancer. They occur in many tissues – for example in the lungs, esophagus, pancreas, throat and pharynx, and on the skin.

10 Mar 2020

Study reports second ever case of a patient to be cured of HIV

A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI.

10 Mar 2020

Clinical trial evaluates effectiveness of spinal cord stimulation in patients with overactive bladder

Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions, such as a spinal cord injury or stroke, and idiopathic (unknown) causes.

10 Mar 2020

Heart Association puts halt to Bayer’s giant displays of baby aspirin

The large red-and-white bins at Walmart pharmacies across the country read, in bold all-caps type: "Approximately every 40 seconds an American will have a heart attack."

10 Mar 2020

How effective is Gabapentin in alcohol use disorder?

A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.

9 Mar 2020

Gene therapy reverses cardiac dysfunction in mice with Barth syndrome

Barth syndrome is a rare metabolic disease in boys caused by mutation of a gene called tafazzin or TAZ. It can cause life-threatening heart failure and also weakens the skeletal muscles, undercuts the immune response, and impairs overall growth.

9 Mar 2020

Comprehensive new clinical guideline on homelessness released

A collaborative approach is required to build healthcare pathways that will end homelessness in Canada, says the Homeless Health Research Network, a pan-Canadian team of experts including researchers from McGill University.

9 Mar 2020

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

In the 2020 February 25 issue of Scientific Reports, a research group from the Department of Hepatology in Osaka City University Graduate School of Medicine, Japan reported that levels of a circulating soluble immune checkpoint protein can be used as a potential marker to predict overall survival in patients with advanced HCC.

9 Mar 2020

New toolkit to repair DNA breaks linked to aging, cancer and MND discovered

A new 'toolkit' to repair damaged DNA that can lead to aging, cancer and Motor Neurone Disease has been discovered by scientists at the Universities of Sheffield and Oxford.

9 Mar 2020

Collaborative approach needed to build pathways to end homelessness in Canada

A collaborative approach is required to build health care pathways that will end homelessness in Canada. Clinicians can play a role by tailoring their interventions using a comprehensive new clinical guideline on homelessness published in CMAJ (Canadian Medical Association Journal).

9 Mar 2020

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Based on proof-of-concept results from clinical trials at University of North Carolina Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.

9 Mar 2020

Gut bacteria can boost effectiveness of cancer immunotherapy, mice study suggests

Could the response to cancer immunotherapy depend on bacteria that originate in the gut and travel to the tumor?

7 Mar 2020

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Harvard University's Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Harvard's Department of Stem Cell and Regenerative Biology, announce the formation of a new NIH-funded Immuno-Engineering to Improve Immunotherapy Center.

7 Mar 2020

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer, has awarded additional funding of up to $16 million to four teams of top researchers as part of its "New Therapies Challenge Grants," the American Association for Cancer Research, Scientific Partner of SU2C, announced today.

5 Mar 2020

Study provides new insight into neurofibromin-deficient ER+ breast cancer

An international team of researchers led by scientists at Baylor College of Medicine has new insights into the function of neurofibromin, a tumor suppressor produced by the NF1 gene.

5 Mar 2020

Therapy News and Research

Baylor College of Medicine and UH team up for new research collaborations

Research introduces a new concept of resectability in pancreatic cancer

The second person cured from HIV goes public

NCCN publishes recommendations for assessing quality improvements in cancer care

Music appears to decrease delirium in critically ill patients

Researchers find way to inactivate cancer protein with the help of another protein

Study reports second ever case of a patient to be cured of HIV

Clinical trial evaluates effectiveness of spinal cord stimulation in patients with overactive bladder

Heart Association puts halt to Bayer’s giant displays of baby aspirin

How effective is Gabapentin in alcohol use disorder?

Gene therapy reverses cardiac dysfunction in mice with Barth syndrome

Comprehensive new clinical guideline on homelessness released

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

New toolkit to repair DNA breaks linked to aging, cancer and MND discovered

Collaborative approach needed to build pathways to end homelessness in Canada

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Gut bacteria can boost effectiveness of cancer immunotherapy, mice study suggests

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News